More on JSPR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.9 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Jasper Therapeutics (NQ:JSPR)
Delayed: 0.48 -0.05 (9.43%)
Prev. Close $0.53  
Open$0.55 
52 Wk High$ 
52 Wk Low$ 
Day High$0.55 
Day Low$0.48 
P/E N/A  
EPS$ 
Volume246,398 


Oct 15, 2026 08:02 AM Jasper Therapeutics completes IgAN cohort enrollment in Phase 2 study
Oct 15, 2026 08:00 AM Form 8-K Jasper Therapeutics, For: Oct 15
Oct 15, 2026 08:00 AM Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
Oct 14, 2026 05:23 PM Form S-3 Jasper Therapeutics,
Oct 14, 2026 05:08 AM William Blair Resumes Jasper Therapeutics (JSPR) at Outperform
Oct 9, 2026 04:53 PM Form PRE 14A Jasper Therapeutics, For: Oct 09
Oct 7, 2026 08:06 AM Form 8-K Jasper Therapeutics, For: Oct 07
Oct 7, 2026 08:03 AM Jasper Therapeutics launches offer to buy back outstanding warrants
Oct 7, 2026 08:00 AM Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
Oct 7, 2026 07:51 AM Form SC TO-I Jasper Therapeutics, Filed by: Jasper Therapeutics, Inc.
View All Articles

Entities mentioned with JSPR

View All Entities